Crawford Investment Counsel Inc. Boosts Position in Danaher Co. (NYSE:DHR)

Crawford Investment Counsel Inc. lifted its holdings in shares of Danaher Co. (NYSE:DHRGet Rating) by 6.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,860 shares of the conglomerate’s stock after purchasing an additional 218 shares during the quarter. Crawford Investment Counsel Inc.’s holdings in Danaher were worth $1,132,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of DHR. Vanguard Group Inc. lifted its position in Danaher by 2.1% in the 1st quarter. Vanguard Group Inc. now owns 51,004,840 shares of the conglomerate’s stock worth $14,961,250,000 after buying an additional 1,044,650 shares during the last quarter. Geode Capital Management LLC lifted its position in Danaher by 2.8% in the fourth quarter. Geode Capital Management LLC now owns 10,539,950 shares of the conglomerate’s stock valued at $3,457,729,000 after purchasing an additional 291,597 shares during the last quarter. Norges Bank bought a new stake in Danaher in the fourth quarter valued at approximately $2,015,889,000. Parnassus Investments LLC lifted its position in Danaher by 1.2% in the first quarter. Parnassus Investments LLC now owns 4,487,356 shares of the conglomerate’s stock valued at $1,316,276,000 after purchasing an additional 55,114 shares during the last quarter. Finally, Fisher Asset Management LLC lifted its position in Danaher by 3.7% in the first quarter. Fisher Asset Management LLC now owns 3,745,126 shares of the conglomerate’s stock valued at $1,098,558,000 after purchasing an additional 132,703 shares during the last quarter. Hedge funds and other institutional investors own 77.27% of the company’s stock.

Insider Buying and Selling

In other Danaher news, EVP Joakim Weidemanis sold 12,000 shares of Danaher stock in a transaction on Monday, July 25th. The stock was sold at an average price of $271.13, for a total transaction of $3,253,560.00. Following the completion of the sale, the executive vice president now directly owns 74,398 shares of the company’s stock, valued at approximately $20,171,529.74. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other news, Director Walter G. Lohr sold 3,906 shares of the business’s stock in a transaction on Friday, July 22nd. The stock was sold at an average price of $273.84, for a total value of $1,069,619.04. Following the completion of the transaction, the director now directly owns 12,115 shares of the company’s stock, valued at approximately $3,317,571.60. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Joakim Weidemanis sold 12,000 shares of the business’s stock in a transaction on Monday, July 25th. The stock was sold at an average price of $271.13, for a total value of $3,253,560.00. Following the completion of the transaction, the executive vice president now directly owns 74,398 shares of the company’s stock, valued at $20,171,529.74. The disclosure for this sale can be found here. In the last three months, insiders sold 40,906 shares of company stock valued at $11,823,179. Insiders own 11.20% of the company’s stock.

Danaher Stock Up 0.8 %

DHR stock opened at $290.42 on Monday. Danaher Co. has a fifty-two week low of $233.71 and a fifty-two week high of $333.96. The business’s 50-day moving average is $277.27 and its two-hundred day moving average is $269.54. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.32 and a current ratio of 1.75. The company has a market cap of $211.26 billion, a price-to-earnings ratio of 34.21, a P/E/G ratio of 1.39 and a beta of 0.88.

Danaher (NYSE:DHRGet Rating) last posted its quarterly earnings data on Thursday, July 21st. The conglomerate reported $2.76 EPS for the quarter, topping the consensus estimate of $2.35 by $0.41. Danaher had a return on equity of 18.57% and a net margin of 20.61%. The firm had revenue of $7.75 billion for the quarter, compared to the consensus estimate of $7.29 billion. During the same quarter last year, the company earned $2.46 earnings per share. The business’s revenue for the quarter was up 7.4% compared to the same quarter last year. As a group, analysts forecast that Danaher Co. will post 10.4 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts have weighed in on the company. Sanford C. Bernstein assumed coverage on Danaher in a research report on Tuesday, August 16th. They issued an “outperform” rating and a $340.00 price objective for the company. Robert W. Baird boosted their price objective on Danaher from $319.00 to $325.00 in a research report on Friday, July 22nd. Cowen lowered their price objective on Danaher to $340.00 in a research report on Friday, July 22nd. KeyCorp reduced their price target on Danaher from $345.00 to $325.00 and set an “overweight” rating on the stock in a research note on Friday, July 22nd. Finally, Credit Suisse Group started coverage on Danaher in a research note on Wednesday, August 24th. They issued an “outperform” rating and a $340.00 target price on the stock. One equities research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Danaher currently has a consensus rating of “Buy” and a consensus price target of $320.73.

About Danaher

(Get Rating)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRGet Rating).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.